Efficacy and Safety of PD-1 Inhibitor Combined with Anlotinib on Advanced Neuroendocrine Carcinoma
Objective To analyze the efficacy and safety of PD-1 inhibitor combined with anlotinib on advanced neuroendocrine carcinoma. Methods We collected the data of patients with advanced neuroendocrine carcinoma who had failed the first-line standard chemotherapy and treated with PD-1 inhibitor combined w...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | ZH |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/186b970ee9bb445ab2de5a5302123faf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!